CSL (ASX:CSL) Total Stockholders Equity : A$25,662 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is CSL Total Stockholders Equity?

CSL's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$25,662 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. CSL's Book Value per Share for the quarter that ended in Dec. 2023 was A$53.12. The ratio of a company's debt over equity can be used to measure how leveraged this company is. CSL's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.70.

CSL Total Stockholders Equity Historical Data

The historical data trend for CSL's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Total Stockholders Equity Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

7,561.87

9,458.20

10,962.74

20,743.78

23,521.14

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															19,618.41	20,743.78	23,231.54	23,521.14	25,662.44

CSL (ASX:CSL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

CSL's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(25662.438	-	0)	/	483.093
	=	53.12

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

CSL's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2121.48	+	15966.378)	/	25662.438
	=	0.70

CSL Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CSL's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL (ASX:CSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (ASX:CSL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CMXHF:USA CSJ:Germany

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.